YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (HK:1558) has released an update.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has announced its inclusion in multiple Hang Seng family of indexes, which are benchmarks of market performance in Hong Kong’s financial markets. This move, effective from September 9, 2024, positions the Company among significant players in the healthcare and pharmaceutical sector and provides a new opportunity for shareholders and investors to assess the company’s market standing.
For further insights into HK:1558 stock, check out TipRanks’ Stock Analysis page.
